Opko Health, Inc. OPK
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -8.26% | -25.81% | -29.52% | -28.26% | -23.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.26% | -25.81% | -29.52% | -28.26% | -23.14% |
| Cost of Revenue | -14.56% | -35.62% | -33.88% | -30.48% | -31.55% |
| Gross Profit | 14.71% | 31.92% | -5.26% | -16.46% | 39.41% |
| SG&A Expenses | -12.19% | -36.68% | -36.39% | -35.26% | -33.31% |
| Depreciation & Amortization | -3.60% | -8.18% | -8.70% | -9.36% | -9.06% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.81% | -30.64% | -29.66% | -27.41% | -27.57% |
| Operating Income | 21.88% | 42.70% | 30.03% | 25.20% | 37.75% |
| Income Before Tax | 32.15% | -6.38% | -53,769.72% | -3,019.08% | -105.25% |
| Income Tax Expenses | -389.85% | -241.35% | -214.26% | -201.68% | -143.80% |
| Earnings from Continuing Operations | 44.64% | 28.06% | -585.79% | -426.51% | -75.68% |
| Earnings from Discontinued Operations | -132.96% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.93% | 58.85% | -445.92% | -324.02% | -34.89% |
| EBIT | 21.88% | 42.70% | 30.03% | 25.20% | 37.75% |
| EBITDA | 38.83% | 63.35% | 43.54% | 35.65% | 52.55% |
| EPS Basic | 18.58% | 58.56% | -363.90% | -307.69% | -31.26% |
| Normalized Basic EPS | -60.47% | 12.01% | -414.14% | -384.41% | 64.74% |
| EPS Diluted | 18.38% | 59.53% | -314.98% | -272.78% | -28.20% |
| Normalized Diluted EPS | -13.62% | 15.14% | -356.18% | -335.97% | 43.28% |
| Average Basic Shares Outstanding | 3.87% | 7.98% | 12.75% | 8.17% | 2.22% |
| Average Diluted Shares Outstanding | -5.09% | -10.35% | -6.91% | -10.50% | 1.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |